{"id":13870,"date":"2018-02-14T11:16:55","date_gmt":"2018-02-14T11:16:55","guid":{"rendered":"https:\/\/arisglobal.com\/bkp-site\/?p=13870"},"modified":"2018-02-14T11:16:55","modified_gmt":"2018-02-14T11:16:55","slug":"push-pull-artificial-intelligence-pharmacovigilance","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/","title":{"rendered":"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance"},"content":{"rendered":"

How is Artificial Intelligence Affecting Drug Safety?<\/h2>\n

Pharmacovigilance is at a crossroads. On the one hand, several factors are pushing life sciences companies to rethink their processes and technologies, while, on the other, technological breakthroughs and large-scale consumer adoption of next-generation platforms are pushing companies toward innovation, such as artificial intelligence in pharmacovigilance.<\/p>\n

The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).<\/p>\n

Understanding the Challenges of Drug Safety & Pharmacovigilance<\/h3>\n

The challenges are many-fold. First, there\u2019s the increasing number of drugs on the market. In 2017, the FDA approved 46 new molecular entities (NMEs). On top of those, several combination products, vaccines, cellular and gene therapies were approved, and more generic variants entered the market. Many of these new medicines are a great deal more complex than small molecule products, and understanding safety for these complex molecules is not straightforward.<\/p>\n

There has been a five-fold increase in adverse events (AEs)<\/strong> to the FDA\u2019s Adverse Event Reporting System (FAERS) from 2004 to 2015, according to one report<\/a>. Other regulators have reported similar trends. The European Medicines Agency noted in its 2015 report on EurdraVigilance for the European Parliament, the Council and the Commission that the number of adverse drug reaction (ADR) reports had continued to rise<\/a>, with a 10% rise in 2015, and a 29% rise in the number of reports submitted directly by European patients and consumers through the national competent authorities.<\/p>\n

The rise in reported AEs and ADRs has a resource and cost implication for PV departments. On top of this, employee satisfaction is affected by increased workload, particularly when it comes to handling manual and repetitive tasks.<\/p>\n

Can AI Help Overcome Drug Safety Challenges?<\/h3>\n

Where, then, do the opportunities for overcoming these challenges lie? Artificial intelligence, sometimes referred to as a fourth industrial revolution \u2013 spanning machine learning, natural language process or natural language generation, and speech and image recognition offers enormous promise. Rapid strides have also been made in other automation technologies, including robotic process automation (RPA).<\/p>\n

The exciting technological developments offer a potential solution to the growing challenges, or pull factors, in PV. Furthermore, AI and RPA<\/strong> are perhaps the best answer to keeping pace with an increasingly tech-savvy consumer, who is not only sharing information online but adding data through wearables and other connected devices.<\/p>\n

By utilizing all these data, it becomes possible to learn individual risk factors based on certain parameters, such as a patient\u2019s demographics, medical history, genetics and socio-economic conditions. AI-driven algorithms make it possible to provide recommendations accompanied by a probability value or a confidence interval, and this might help a company to decide not only which patients should use or avoid the product, but even which markets might be most suitable for product launch.<\/p>\n

In so doing, the expectation is that there would be fewer AEs reported, which is not only good for the patient but also for the company.<\/p>\n

Over the coming weeks, we will share insights on the role AI already is playing and its future potential in PV. Find out more about the role automation plays in pharmacovigilance<\/a> by listening to the on-demand webcast \u201cProductivity, Compliance and Quality: The Holy Grail in Pharmacovigilance<\/em><\/strong>.“<\/em><\/strong><\/p>\n

Contact Us<\/h2>\n

Pharmacovigilance is at a crossroads. On the one hand, several factors are pushing life sciences companies to rethink their processes and technologies, while, on the other, technological breakthroughs and large-scale consumer adoption of next-generation platforms are pushing companies toward innovation, such as artificial intelligence in pharmacovigilance.<\/p>\n

The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities). Contact the pharmacovigilance experts<\/a> at ArisGlobal today!<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[93,96],"class_list":["post-13870","post","type-post","status-publish","format-standard","hentry","category-blogs","tag-pharmacovigilance","tag-adverse-event"],"acf":[],"yoast_head":"\nArtificial Intelligence in Pharmacovigilance | ArisGlobal<\/title>\n<meta name=\"description\" content=\"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance\" \/>\n<meta property=\"og:description\" content=\"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-14T11:16:55+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance\",\"datePublished\":\"2018-02-14T11:16:55+00:00\",\"dateModified\":\"2018-02-14T11:16:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\"},\"wordCount\":630,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"keywords\":[\"Pharmacovigilance\",\"adverse event\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\",\"url\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\",\"name\":\"Artificial Intelligence in Pharmacovigilance | ArisGlobal\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2018-02-14T11:16:55+00:00\",\"dateModified\":\"2018-02-14T11:16:55+00:00\",\"description\":\"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Artificial Intelligence in Pharmacovigilance | ArisGlobal","description":"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/","og_locale":"en_US","og_type":"article","og_title":"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance","og_description":"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog","og_url":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2018-02-14T11:16:55+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance","datePublished":"2018-02-14T11:16:55+00:00","dateModified":"2018-02-14T11:16:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/"},"wordCount":630,"commentCount":0,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"keywords":["Pharmacovigilance","adverse event"],"articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/","url":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/","name":"Artificial Intelligence in Pharmacovigilance | ArisGlobal","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2018-02-14T11:16:55+00:00","dateModified":"2018-02-14T11:16:55+00:00","description":"Connecting the pull of adverse events and the push of artificial intelligence in pharmacovigilance for patient safety. Read the Blog","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/blogs\/push-pull-artificial-intelligence-pharmacovigilance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"Benefits & Challenges of Artificial Intelligence in Pharmacovigilance"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/13870"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=13870"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/13870\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=13870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=13870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=13870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}